Long-term spironolactone treatment reduces coronary TRPC expression, vasoconstriction, and atherosclerosis in metabolic syndrome pigs. [electronic resource]
Producer: 20180521Description: 54 p. digitalISSN:- 1435-1803
- Animals
- Calcium Signaling -- drug effects
- Cells, Cultured
- Coronary Artery Disease -- genetics
- Coronary Vessels -- drug effects
- Disease Models, Animal
- Down-Regulation
- Drug Administration Schedule
- Endothelium, Vascular -- drug effects
- Macrophages -- drug effects
- Metabolic Syndrome -- drug therapy
- Mineralocorticoid Receptor Antagonists -- administration & dosage
- Muscle, Smooth, Vascular -- drug effects
- Spironolactone -- administration & dosage
- Swine
- Swine, Miniature
- TRPC Cation Channels -- drug effects
- TRPC6 Cation Channel -- drug effects
- Time Factors
- Tissue Culture Techniques
- Vasoconstriction -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.